Kevzara (sarilumab) is a prescription drug used to treat rheumatoid arthritis in certain situations. Kevzara’s cost may depend on factors such as your dosage, whether you have health insurance, and ...
Approval in patients with pJIA weighing 63kg or greater adds to Kevzara’s position in treating adult chronic inflammatory conditions of moderately to severely active rheumatoid arthritis and ...
TARRYTOWN, N.Y. and BRIDGEWATER, N.J., Oct. 19, 2018 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi will present data from analyses of the Kevzara ® (sarilumab) Phase 3 ...
The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper. The Food and ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced they have started a clinical program evaluating Kevzara® (sarilumab) in patients hospitalized with severe COVID-19 infection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback